Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lounis

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|September 29, 2005
Efficient intermittent rifapentine-moxifloxacin-containing short-course regimen for treatment of tuberculosis in miceN Veziris, N Lounis, A Chauffour, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 12, 2003
Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosisN Lounis, C Maslo, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in miceA Bentoucha, J Robert, H Dega, et al.
Medecine Et Maladies Infectieuses|December 4, 2009
[R207910 (TMC207): a new antibiotic for the treatment of tuberculosis]N Lounis, J Guillemont, N Veziris, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Efficacies of clarithromycin regimens against Mycobacterium xenopi in miceN Lounis, C Truffot-Pernot, A Bentoucha, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 13, 2001
Iron and Mycobacterium tuberculosis infectionN Lounis, C Truffot-Pernot, J Grosset, et al.
Antimicrobial Agents and Chemotherapy|August 4, 1998
In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosisB Ji, N Lounis, C Maslo, et al.
American Journal of Respiratory and Critical Care Medicine|May 29, 1998
Once-weekly rifapentine-containing regimens for treatment of tuberculosis in miceJ Grosset, N Lounis, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2006
Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosisM Ibrahim, K Andries, N Lounis, et al.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
Can some growth hormone (GH)-deficient children benefit from combined therapy with gonadotropin-releasing hormone analogs and GH? Results of a retrospective studyM Tauber, B Berro, V Delagnes, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|September 29, 2005
Efficient intermittent rifapentine-moxifloxacin-containing short-course regimen for treatment of tuberculosis in miceN Veziris, N Lounis, A Chauffour, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 12, 2003
Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosisN Lounis, C Maslo, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in miceA Bentoucha, J Robert, H Dega, et al.
Medecine Et Maladies Infectieuses|December 4, 2009
[R207910 (TMC207): a new antibiotic for the treatment of tuberculosis]N Lounis, J Guillemont, N Veziris, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Efficacies of clarithromycin regimens against Mycobacterium xenopi in miceN Lounis, C Truffot-Pernot, A Bentoucha, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 13, 2001
Iron and Mycobacterium tuberculosis infectionN Lounis, C Truffot-Pernot, J Grosset, et al.
Antimicrobial Agents and Chemotherapy|August 4, 1998
In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosisB Ji, N Lounis, C Maslo, et al.
American Journal of Respiratory and Critical Care Medicine|May 29, 1998
Once-weekly rifapentine-containing regimens for treatment of tuberculosis in miceJ Grosset, N Lounis, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2006
Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosisM Ibrahim, K Andries, N Lounis, et al.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
Can some growth hormone (GH)-deficient children benefit from combined therapy with gonadotropin-releasing hormone analogs and GH? Results of a retrospective studyM Tauber, B Berro, V Delagnes, et al.
Pageof 3